CALL US

News

ACRP Features Dr. Daniel Eisenman in Gene Therapy Research Article

August 9th, 2017

Daniel Eisenman, PhD, RBP, SM(NRCM), CBSP, Director of Biosafety Services at Schulman IRB, discusses the rise in risks and opportunities for gene therapy research in a recent ACRP article.

“Despite the promising prospects, this field is not without additional risks, which must be carefully assessed and managed,” said Dr. Eisenman.

Dr. Eisenman will host an ACRP webinar on August 22, “An Introduction to Gene Therapy” where he will educate attendees on how to navigate gene therapy research and maximize its benefits.

Read the full article here.

BACK TO NEWS